Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
First Half of Year Yields Earnings Growth for LabCorp, Quest
From - Laboratory Industry Report
LabCorp and Quest Diagnostics reported significant jumps in profitability during the second quarter of 2016 and throughout…
Industry Questions How Many Hospital Labs Will Be Reporting Under PAMA
From - G2 Compliance Advisor
When the Centers for Medicare & Medicaid Services (CMS) announced in mid-June the final rules governing the Protecting the…
House Committee Questions CDC on Capacity of Laboratory Response Network
From - National Intelligence Report
The U.S. House of Representatives Energy and Commerce Committee recently requested that the Centers for Disease Control and Prevention (CDC) provide information to the…
LabCorp Strikes Deal to Acquire Sequenom
From - Laboratory Industry Report
LabCorp has entered into another big deal, coming to terms to acquire neonatal specialty lab Sequenom for…
Theranos Announces Appeal of CMS Sanctions
From - G2 Compliance Advisor
Theranos has announced that it is appealing the Centers for Medicare & Medicaid's threatened sanctions. The announcement also indicated that…
FDA Considers Liquid Biopsies
From - National Intelligence Report
In addition to laboratory developed tests and next generation sequencing, could the FDA be looking to impose standards or guidance governing use of…
Re-considering PSA Screening Strategies to Catch Aggressive Cases
From - Diagnostic Testing & Emerging Technologies
The number of new cases of metastatic prostate cancer climbed 72 percent from 2004 to 2013, according to a controversial new study published…